Butyrate-Producing Bacteria and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES)
- PMID: 35972231
- PMCID: PMC9630078
- DOI: 10.2337/db22-0168
Butyrate-Producing Bacteria and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES)
Abstract
Gut microbiome studies have documented depletion of butyrate-producing taxa in type 2 diabetes. We analyzed associations between butyrate-producing taxa and detailed measures of insulin homeostasis, whose dysfunction underlies diabetes in 224 non-Hispanic Whites and 129 African Americans, all of whom completed an oral glucose tolerance test. Stool microbiome was assessed by whole-metagenome shotgun sequencing with taxonomic profiling. We examined associations among 36 butyrate-producing taxa (n = 7 genera and 29 species) and insulin sensitivity, insulin secretion, disposition index, insulin clearance, and prevalence of dysglycemia (prediabetes plus diabetes, 46% of cohort), adjusting for age, sex, BMI, and race. The genus Coprococcus was associated with higher insulin sensitivity (β = 0.14; P = 0.002) and disposition index (β = 0.12; P = 0.012) and a lower rate of dysglycemia (odds ratio [OR] 0.91; 95% CI 0.85-0.97; P = 0.0025). In contrast, Flavonifractor was associated with lower insulin sensitivity (β = -0.13; P = 0.004) and disposition index (β = -0.11; P = 0.04) and higher prevalence of dysglycemia (OR 1.22; 95% CI 1.08-1.38; P = 0.0013). Species-level analyses found 10 bacteria associated with beneficial directions of effects and two bacteria with adverse associations on insulin homeostasis and dysglycemia. Although most butyrate producers analyzed appear to be metabolically beneficial, this is not the case for all such bacteria, suggesting that microbiome-directed therapeutic measures to prevent or treat diabetes should be targeted to specific butyrate-producing taxa rather than all butyrate producers.
© 2022 by the American Diabetes Association.
Figures
Similar articles
-
Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES).Diabetes. 2024 Mar 1;73(3):385-390. doi: 10.2337/db23-0401. Diabetes. 2024. PMID: 37992186
-
Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies.JAMA Netw Open. 2021 Jul 1;4(7):e2118811. doi: 10.1001/jamanetworkopen.2021.18811. JAMA Netw Open. 2021. PMID: 34323983 Free PMC article.
-
Rationale, design and baseline characteristics of the Microbiome and Insulin Longitudinal Evaluation Study (MILES).Diabetes Obes Metab. 2020 Nov;22(11):1976-1984. doi: 10.1111/dom.14145. Epub 2020 Aug 20. Diabetes Obes Metab. 2020. PMID: 32687239 Free PMC article.
-
The potential of outdoor environments to supply beneficial butyrate-producing bacteria to humans.Sci Total Environ. 2021 Jul 10;777:146063. doi: 10.1016/j.scitotenv.2021.146063. Epub 2021 Feb 25. Sci Total Environ. 2021. PMID: 33684759 Review.
-
Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.Clin Exp Immunol. 2014 Jul;177(1):24-9. doi: 10.1111/cei.12293. Clin Exp Immunol. 2014. PMID: 24528224 Free PMC article. Review.
Cited by
-
Association between gut microbiota and diabetic nephropathy: a two-sample mendelian randomization study.BMC Endocr Disord. 2024 Oct 11;24(1):214. doi: 10.1186/s12902-024-01746-7. BMC Endocr Disord. 2024. PMID: 39390505 Free PMC article.
-
Exploring the design of clinical research studies on the efficacy mechanisms in type 2 diabetes mellitus.Front Endocrinol (Lausanne). 2024 Sep 20;15:1363877. doi: 10.3389/fendo.2024.1363877. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39371930 Free PMC article. Review.
-
Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals.BMC Med. 2024 Sep 2;22(1):346. doi: 10.1186/s12916-024-03548-z. BMC Med. 2024. PMID: 39218875 Free PMC article.
-
Gut microbiome related to metabolic diseases after moderate-to-vigorous intensity exercise.J Exerc Sci Fit. 2024 Oct;22(4):375-382. doi: 10.1016/j.jesf.2024.07.003. Epub 2024 Jul 25. J Exerc Sci Fit. 2024. PMID: 39185003 Free PMC article.
-
Diet and the Gut Microbiome as Determinants Modulating Metabolic Outcomes in Young Obese Adults.Biomedicines. 2024 Jul 18;12(7):1601. doi: 10.3390/biomedicines12071601. Biomedicines. 2024. PMID: 39062174 Free PMC article.
References
-
- Centers for Disease Control and Prevention . National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2020. Atlanta, U.S. Department of Health and Human Services, 2020
-
- Shah MH, Piaggi P, Looker HC, Paddock E, Krakoff J, Chang DC. Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans. Diabetologia 2021;64:914–922 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
